Security Snapshot

ICU MEDICAL INC/DE - Common Stock (ICUI) Institutional Ownership

CUSIP: 44930G107

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

290

Shares (Excl. Options)

25,641,850

Price

$142.67

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
ICUI on Nasdaq
Underlying class
Common Stock
Shares outstanding
24,701,460
Price per share
$129.15
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
25,641,850
Total reported value
$3,660,341,422
% of total 13F portfolios
0%
Share change
-846,309
Value change
-$111,554,079
Number of holders
290
Price from insider filings
$129.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ICUI - ICU MEDICAL INC/DE - Common Stock is tracked under CUSIP 44930G107.
  • 290 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 290 to 17 between Q4 2025 and Q1 2026.
  • Reported value moved from $3,660,341,422 to $4,823,334.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 290 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 44930G107?
CUSIP 44930G107 identifies ICUI - ICU MEDICAL INC/DE - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of ICU MEDICAL INC/DE - Common Stock (ICUI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10% 0% $326,429,794 +$272,229 2,470,146 +0.08% JANUS HENDERSON GROUP PLC 30 Jun 2025

As of 31 Dec 2025, 290 institutional investors reported holding 25,641,850 shares of ICU MEDICAL INC/DE - Common Stock (ICUI). This represents 104% of the company’s total 24,701,460 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ICU MEDICAL INC/DE - Common Stock (ICUI) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 3,588,155 +1.9% 0.01% $511,922,073
VANGUARD GROUP INC 11% 2,714,746 +3.4% 0.01% $387,312,811
JANUS HENDERSON GROUP PLC 10% 2,576,756 +4.2% 0.16% $367,625,308
FULLER & THALER ASSET MANAGEMENT, INC. 5.1% 1,265,799 -8.6% 0.61% $180,591,541
STATE STREET CORP 3.8% 942,670 +2.8% 0% $134,490,729
DIMENSIONAL FUND ADVISORS LP 3.7% 920,776 +5.5% 0.03% $131,370,011
SCHRODER INVESTMENT MANAGEMENT GROUP 3.1% 765,395 -3.9% 0.08% $110,699,079
AMERIPRISE FINANCIAL INC 2.7% 661,389 -18% 0.02% $94,360,554
River Road Asset Management, LLC 2.6% 650,872 -0.04% 1% $92,859,908
GEODE CAPITAL MANAGEMENT, LLC 2.4% 593,485 +0.03% 0.01% $84,685,913
NEUBERGER BERMAN GROUP LLC 2.3% 563,833 -12% 0.06% $80,442,055
JPMORGAN CHASE & CO 2.1% 529,110 -22% 0.01% $75,488,193
MORGAN STANLEY 2.1% 518,635 -8.2% 0% $73,993,925
NORGES BANK 1.6% 407,115 0.01% $58,083,097
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.5% 380,463 -12% 0.37% $54,281,081
FMR LLC 1.5% 362,460 -0.77% 0% $51,712,132
Defilade Capital Management, L.P. 1.4% 340,745 0% 6.6% $48,614,089
NORTHERN TRUST CORP 1.4% 338,819 -12% 0.01% $48,339,307
Point72 Asset Management, L.P. 1.4% 337,742 +551% 0.08% $48,185,651
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 309,629 +0.78% 0.01% $44,174,769
Thrivent Financial for Lutherans 1.2% 303,457 +1604% 0.08% $43,294,000
BANK OF AMERICA CORP /DE/ 1.2% 298,231 +19% 0% $42,548,618
GOLDMAN SACHS GROUP INC 1.2% 284,551 +2.1% 0.01% $40,596,962
Quantinno Capital Management LP 1.1% 278,707 +10% 0.08% $39,763,128
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 1.1% 273,391 0% 0.06% $39,005,000

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 37,347 $4,823,334 -$481,735 $129.15 17
2025 Q4 25,641,850 $3,660,341,422 -$111,554,079 $142.67 290
2025 Q3 25,796,286 $3,091,441,219 +$77,553,211 $119.96 268
2025 Q2 25,082,538 $3,314,262,195 +$97,749,003 $132.15 273
2025 Q1 24,312,384 $3,381,985,980 +$22,039,356 $138.86 281
2024 Q4 24,213,401 $3,756,909,626 -$58,516,049 $155.17 285
2024 Q3 24,553,720 $4,467,331,041 +$76,905,236 $182.22 287
2024 Q2 23,790,393 $2,825,088,620 +$149,203,804 $118.75 256
2024 Q1 22,617,632 $2,427,031,471 +$116,351,455 $107.32 251
2023 Q4 21,600,686 $2,154,454,730 -$89,807,764 $99.74 241
2023 Q3 22,298,221 $2,653,725,397 -$35,106,953 $119.01 215
2023 Q2 22,249,048 $3,964,270,637 -$74,461,498 $178.19 227
2023 Q1 22,697,462 $3,743,979,121 +$70,541,615 $164.96 231
2022 Q4 22,295,759 $3,511,926,675 +$39,756,872 $157.48 241
2022 Q3 22,630,155 $3,408,280,475 -$240,293,324 $150.60 231
2022 Q2 21,624,606 $3,556,543,462 +$100,918,106 $164.39 246
2022 Q1 20,908,251 $4,657,377,472 +$150,898,618 $222.64 282
2021 Q4 20,185,157 $4,789,939,188 +$34,827,837 $237.34 288
2021 Q3 19,964,154 $4,660,018,823 -$53,955,352 $233.38 272
2021 Q2 20,303,486 $4,177,920,660 +$50,461,509 $205.80 266
2021 Q1 20,080,347 $4,125,473,068 +$114,043,017 $205.44 277
2020 Q4 19,530,259 $4,188,765,735 +$40,730,429 $214.49 273
2020 Q3 19,335,530 $3,533,762,551 -$33,121,822 $182.76 273
2020 Q2 19,504,752 $3,594,237,202 +$747,251 $184.31 285
2020 Q1 19,503,919 $3,933,938,959 -$44,075,766 $201.77 264
2019 Q4 19,759,409 $3,697,111,618 +$109,354,567 $187.12 262
2019 Q3 19,175,080 $3,060,005,447 -$169,056,479 $159.60 246
2019 Q2 19,515,114 $4,913,528,084 +$236,037,417 $251.91 266
2019 Q1 18,741,811 $4,485,031,238 -$83,298,148 $239.33 285
2018 Q4 19,044,665 $4,373,102,047 +$710,058,537 $229.63 286
2018 Q3 15,694,440 $4,437,405,702 +$195,341,135 $282.75 344
2018 Q2 15,060,933 $4,422,798,114 +$58,940,996 $293.65 339
2018 Q1 14,873,366 $3,747,945,182 -$171,234,588 $252.40 286
2017 Q4 15,562,889 $3,361,849,633 -$74,371,611 $216.00 254
2017 Q3 15,896,325 $2,954,582,018 +$34,239,606 $185.85 224
2017 Q2 15,722,627 $2,705,181,843 +$285,356,060 $172.50 225
2017 Q1 15,533,117 $2,371,867,645 +$304,529,806 $152.70 229
2016 Q4 15,216,010 $2,241,820,263 +$103,756,391 $147.35 243
2016 Q3 14,507,458 $1,832,998,453 +$26,003,941 $126.38 226
2016 Q2 14,325,038 $1,615,346,710 -$1,974,085 $112.75 215
2016 Q1 14,374,065 $1,496,358,514 +$37,499,197 $104.10 211
2015 Q4 14,089,884 $1,588,866,427 -$25,778,655 $112.78 223
2015 Q3 14,320,264 $1,564,865,155 -$33,583,970 $109.50 205
2015 Q2 14,680,545 $1,404,322,180 +$22,278,781 $95.66 194
2015 Q1 14,454,758 $1,346,125,061 +$33,464,178 $93.14 185
2014 Q4 14,150,736 $1,159,233,343 +$12,688,058 $81.90 192
2014 Q3 14,295,859 $917,513,365 -$3,357,133 $64.18 171
2014 Q2 14,359,564 $873,192,036 +$5,449,682 $60.81 161
2014 Q1 14,274,842 $854,737,039 +$41,894,072 $59.88 166